Japan Becomes First Country To Approve Ronapreve Covid Treatment
Muhammad Irfan Published July 20, 2021 | 04:31 PM
Swiss pharmaceutical giant Roche said Tuesday that Japan had become the first country to fully approve its Ronapreve antibody treatment for patients with mild to moderate Covid-19
Geneva, (UrduPoint / Pakistan Point News - 20th Jul, 2021 ) :Swiss pharmaceutical giant Roche said Tuesday that Japan had become the first country to fully approve its Ronapreve antibody treatment for patients with mild to moderate Covid-19.
The approval was based on phase 3 trials finding that the antibody cocktail dramatically reduced the likelihood that mild or moderate Covid patients would develop into serious illness causing hospitalisation or death.
Ronapreve, developed in cooperation with US biotech firm Regeneron, was approved by Japan's ministry of health, labour and welfare, Roche said in a statement, confirming it was the "first country" to do so.
"Ronapreve has been shown to improve survival in high-risk, non-hospitalised Covid-19 patients by reducing the risk of hospitalisation and death," Roche chief medical officer and product development chief Levi Garraway said in a statement.
"Its ability to retain activity against emerging variants, including the Delta variant, has been demonstrated in preclinical studies," he said.
Roche said the phase 3 trials of Ronapreve had shown that high-risk non-hospitalised patients treated with the drug had a 70 percent reduction in subsequent hospitalisation and death.
It also shorted the period of symptomatic illness by four days, Roche said, adding that the phase 1 trials had showed the safety and tolerability of the drug among the Japanese population.
Outside Japan, the antibody combination has been authorised for emergency or temporary pandemic use in a number of countries and regions, including the European Union, United States, India, Switzerland and Canada, Roche said.
The blend is currently undergoing a rolling review by the European Medicines Agency, which has granted its use as a treatment option for Covid patients who do not require oxygen, but who are at high risk of developing severe disease.
Related Topics
Recent Stories
Today Gold Rate in Pakistan 27 April 2024
HEC reviews curricula for environmental sciences degree programme
ICC Asia looking forward to an action-packed Asia Cricket Week
Yuvraj Singh named ICC Men’s T20 World Cup 2024 Ambassador
Greece hands Olympic flame to 2024 Paris Games hosts
Two Kyiv hospitals evacuating over feared Russian strikes
World must act on neurotech revolution, say experts
Charles & Catherine's cancer diagnoses
Champions Alcaraz and Sabalenka through in Madrid Open
King Charles to resume some public duties during cancer treatment: palace
US defense chief announces $6 bn in security aid for Ukraine
Heavy rains cause damage to Spezand-Taftan railway track
More Stories From Health
-
Vaccines save at least 154 million lives in 50 years: WHO
3 days ago -
UHS to issue MBBS degrees within three months after final result
3 days ago -
Rawalpindi woman gives birth to six babies
8 days ago -
DC calls for intensive anti-polio drive in ICT
9 days ago -
World Hemophilia Day observed to underscore importance of providing comprehensive care
9 days ago -
Six in a family with heart on the 'right side'
9 days ago
-
Diabetic disease increasing rapidly : Dr. Noor Elahi Memon
10 days ago -
World Hemophilia Day observed
10 days ago -
ATC dismisses bail petition of doctor involved in illegal kidneys transplant
17 days ago -
Dr. Shehzad warns against deviation from WHO guidelines on anti-smoking
18 days ago -
Health activists express concerns over attempts to derail tobacco control
20 days ago -
UHS declares MBBS first prof, MS urology exam results
29 days ago